Prostate Specific Antigen Versus Prostate Specific Antigen Density as a Prognosticator of Pathological Characteristics and Biochemical Recurrence Following Radical Prostatectomy

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 1780-1784

  Magheli, Ahmed ^a   Rais Bahrami, Soroush ^a   Trock, Bruce J ^a   Humphreys, Elizabeth B ^a   Partin, Alan W ^a   Han, Misop ^a   Gonzalgo, Mark L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

neoplasm recurrence, local; prostate; prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

ADENOCARCINOMA; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE;

EID: 41749100122     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.01.032     Document Type: Article

References (16)

1. Semjonow A., Hamm M., Rathert P., and Hertle L. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer. Br J Urol 73 (1994) 538
2. Collins G.N., Lee R.J., McKelvie G.B., Rogers A.C., and Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 71 (1993) 445
3. Stamey T.A., Johnstone I.M., McNeal J.E., Lu A.Y., and Yemoto C.M. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J Urol 167 (2002) 103
4. Ung J.O., Richie J.P., Chen M.H., Renshaw A.A., and D'Amico A.V. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60 (2002) 458
5. Khan M.A., Han M., Partin A.W., Epstein J.I., and Walsh P.C. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 62 (2003) 86
6. Benson M.C., Whang I.S., Pantuck A., Ring K., Kaplan S.A., Olsson C.A., et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147 (1992) 815
7. Freedland S.J., Wieder J.A., Jack G.S., Dorey F., Dekernion J.B., and Aronson W.J. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. J Urol 168 (2002) 110
8. Jones T.D., Koch M.O., Bunde P.J., and Cheng L. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?. BJU Int 97 (2006) 480
9. Catalona W.J., Southwick P.C., Slawin K.M., Partin A.W., Brawer M.K., Flanigan R.C., et al. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology 56 (2000) 255
10. Radwan M.H., Yan Y., Luly J.R., Figenshau R.S., Brandes S.B., Bhayani S.B., et al. Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure. Urology 69 (2007) 1121
11. Freedland S.J., Kane C.J., Presti Jr. J.C., Terris M.K., Amling C.L., Dorey F., et al. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. J Urol 169 (2003) 969
12. Kundu S.D., Roehl K.A., Yu X., Antenor J.A., Suarez B.K., and Catalona W.J. Prostate specific antigen density correlates with features of prostate cancer aggressiveness. J Urol 177 (2007) 505
13. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350 (2004) 2239
14. Brassell S.A., Kao T.C., Sun L., and Moul J.W. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer. Urology 66 (2005) 1229
15. Kimura A., Nakamura S., Niizuma M., Hoshino T., Niijima T., Ohashi Y., et al. Quantitative analysis of ultrasonogram of the prostate. J Clin Ultrasound 14 (1986) 501
16. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D., Sanders M.M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 (2005) 1248